ADHD
 Home | Free Articles About ADHD | Links | | Contact
ADHD articles
The CDC Defines ADHD As A “Neurobehavioral Disorder Characterized By Pervasive Inattention And/Or Hyperactivity-Impulsivity And Resulting In Significant Functional Impairment.” ADHD—Also Known As Attention Deficit Hyperactivity Disorder—Affects Many People In This Country. That Is Why We've Decided To Launch This Site. Welcome To ADHDupdates.com. This Site Is A Free Information Resource That Will Answer All Your Questions About ADHD. As You Explore This Site, You'll Discover...
Waking Up From The Homework Nightmare
Step By Step Guide Through A Night Of Homework, For Parents Whose Kids Need Lots Of Hand Holding And Help - Especially T...
Old Me New Me, Downloads For Kids
Stories And Guided Imagery Downloads To Help Children And Teens With Behavioral Problems, Anxiety And Adhd.
Dr. C. E. Gant Alternative Health Membership - Recurring
A Science Based Alternative/natural Approach To Treating Adhd, Drug Addictions, And Other Health Conditions. Dr. C E Gan...

Everything You Must Know About ADHD, Attention Deficit Disorder, Attention Deficit Disorder Medicine, ADHD Medication, And ADHD Camps.

Press  For A Message
Latest Related Articles About ADHD
ADHD and Fungal Parasites
There is new evidence that many kids diagnosed with ADHD may actually be suffering from an infestation of fungal parasites. ADHD is a very rapidly...
Continue Reading

Millions Have Misused ADHD Drugs
A study released this week estimates that more than 7 million Americans have misused Adderall, Ritalin and other stimulant medications used to...
Continue Reading

Do You Know What Day January 17th Is
Do you know what day January 17th is? Here's a hint: it has to do with New Year's Resolutions. If youre like most Americans, January brings a...
Continue Reading

Looking For More Articles Related To ADHD?


Attention Deficit Disorder A To Z
ADHD
Comprehensive Guide to ADHD for parents.

ADD To C3 Kids
ADHD
The All-Natural, Drug-Free Way For Children, Teens And Adults To Win Against ADD And ADHD.

Old Me New Me
ADHD
Stories And Guided Imagery On Cd To Help Children And Teens With Behavioral Problems, Anxiety And ADHD.

ADHD
Poll

 
 
The New ADHD Medications
Recognizing & Treating Adhd - * $18.67 Payout! 55% Commission!
Top Adhd Solution The Latest Affiliate Tools Here: www.recognizingadhd....tml

How To Conquer Add.
Number 1 Guide On How To Cope With Attention Deficit Disorder, Add - Adhd. Earn 75% Per Sale. High Conversion Rate - Aff...

The Attention Handbook - Proven Adhd Treatments & Remedies
High $45 Commissions! A Different Kind Of Adhd Book! Written By Someone With Adhd, Who Has Counseled Hundreds Of People ...

Author: Jeannine Virtue

Pharmaceutical companies vying for Ritalins hefty market share are coming up with new formulas and aggressive campaign ads to compete in this $1 billion per year ADHD drug industry.
Pharmaceutical companies introduced five new drugs to treat ADHD in the past five years, with another ADHD drug expected on the market in early 2003 and more are being developed.
The relative newcomers Adderall and the drug Concerta are now joined by Metadate CD, Ritalin LA and Focalin. Another formula, Atomoxetine, should hit the market in just a few months.
The new ADHD drugs give people choosing drug therapy wider options. Yet, parents, doctors, the FDA and the DEA alike worry that the unprecedented marketing tactics will further drive up demand for ADHD medications, as well as increase drug abuse for these high powered drugs.
Ritalin enjoyed the ADHD corner market for decades. Adderall, with its longer acting formula, jumped in for its share in 1996 and quickly began chiseling at Ritalins market share. The drug Concerta, a reformulation of Ritalin, followed in 2000. Then, Metadate CD and Focalin appeared. Not willing to lose its share in the market, Ritalin makers began developing new formulas, the first - Ritalin LA - reaching FDA approval in June. In late November the FDA approved Eli Lilly and Companys new ADHD formulation, Strattera (atomoxetine).
New ADHD formulas hitting the market is not all that surprising. After all, the market is wide open and growing. New prescriptions for Attention Deficit Disorder increased almost 40 percent over the past five years. Last year doctors wrote 20 million prescriptions for ADHD medications. More American children are diagnosed with Attention Deficit than in any other country in the world.
Concerta, Adderall, Metadate CD, Ritalin LA, Focalin all high potential for side effects, drug dependency and abuse and are closely related to illegal street drugs. Strattera is different in that this is the first non-stimulant medication.
It is ironic though that every day millions of children line up to the counter for their dose of meds while the person caught in possession of these drugs without a prescription face felony charges. These drugs cannot be good for young minds and young bodies.
Of the less severe side effects, children might lose weight, have problems falling asleep, have decreased appetite, and temporarily grow more slowly while taking ADHD medications.
Other side effects can include cardiac arrhythmia, depression, psychosis, facial tics, liver damage, abuse and addiction. Some doctors also believe that some ADHD medications may also worsen the symptoms of Tourette's syndrome.
What's worse, ADHD medications do not always work, do not treat the core cause of Attention Deficit Disorder and could have long-term negative effects. Parents need to be clear about the benefits, as well as the potential side effects of ADHD medications.
Still, more than enough doctors willingly diagnose children as Attention Deficit and cut a prescription. More than enough parents willingly place their children on psychotropic drugs. More than enough teachers and school administrators encourage parents to "do the right thing for their child" to make their child more complaint in school.
The more surprising aspect of this wave of new ADHD medications is the aggressive marketing of narcotics straight to the consumer. ADHD drug makers stepped over a 30-year international treaty agreement not to advertise controlled substances that have high potential for abuse last year when they began marketing their magic pills.
These Schedule II controlled substances are of the most addictive and abused drugs that are still legal.
Full-page color advertisement for ADHD medications began splashing across the pages of women's magazines. Metadate CD, Adderall and Concerta ads show smiling children and their proud mothers touting the wonders of such ADHD medications.
Metadate CD, introduced in April, launched ads in nearly a dozen women's magazines this year. The Drug Enforcement Agency sent a cease-and-desist letter to the makers of Metadate CD after the ads appeared yet the pharmaceutical company insisted that it did no wrong.
The DEA closely watches ADHD medication prescriptions and its advertising. ADHD medications are most-stolen prescriptions and the most-abused legal drugs. According to the DEA, the drug thieves, drug dealers and drug abusers are almost always children.
Adderall and Concerta advertisements appeared in September, just in time for the back-to-school children. These companies did not name the product in the ad but listed a toll free number for parents to call if they wanted more information.
Concerta manufacturers also began airing 60-second ads on cable TV channels. For the first time ever, Schedule II drugs found their way to mainstream television marketing.
The public can expect continued advertising as drug makers attempt to convince the public that their medications are better than the rest. Thus far, the makers of Ritalin have not marketed directly to consumers.

About the Author

Jeannine Virtue is a freelance journalist and mother of an Attention Deficit Disorder son. Visit Virtue's web site at www.add-adhd-help-center.com to learn about effective drug-free alternatives to ADHD medications.

Article Keywords:
ADHD







A Quick Note From The Publisher...

If you like the article above, you may be interested in the following article which is also related to ADHD...

The Suicide Antidepressant Link in Adults
The FDA has acknowledged the link between antidepressants and the increased risk of suicide in children, adolescents and adults are also at risk for suicidal thoughts and actions while taking SSRI (selective serotonin reuptake inhibitor) antidepressants. In 2004 the FDA acknowledged the suicide/antidepressant link with children and now requires "Black Box" labeling to alert parents of the harm that can befall their child while taking antidepressants. That warning has now spread to all age groups. The FDA has now issued a Public Health Advisory (PHA) calling for an update to health care providers and patients about the recent scientific research and publications that there is an increased risk of suicidal thought and behaviors in adults taking antidepressant medication. The FDA, using a similar approach that was used in the evaluation of the risks of increased suicidal thoughts and behaviors in their pediatric studies, requested that...
Continue Reading


ADHD,

Attention Deficit Disorder
News

ADHD

Research and Markets: Global ADHD Drugs Market 2014-2018
Research and Markets has announced the addition of the "Global ADHD Drugs Market 2014-2018" report to their of

Shire Canada ADHD Scholarship Program: 2014 winners announced
MONTREAL, Oct. 30, 2014 /CNW Telbec/ - Shire Canada Inc. is pleased to announce the winners of the second edition of the Shire Canada ADHD Scholarship Program. The 2014 winners of the Shire Canada ADHD Scholarship Program are: Each winner will receive a monetary prize of $1,500, to help with tuition fees, in addition to being entitled to one year's worth of ADHD coaching services provided by ...

ADHD seminar planned in Manchester
ADHD: Myths, Realities and Practical Strategies to Manage It Sue West, an Amherst-based ADHD and life management coach, will present workshops about ADHD in Manchester and Chicago this November. At 6 p.m. Nov. 18 in Manchester, Sue will present “ADHD: Myths, Realities and Practical Strategies to Manage It,” a talk that is open to the public for a small visitor’s fee. The talk’s description: Do ...

Alcobra Applies Revisionist History to ADHD Drug Study Analysis
TEL AVIV, Israel (TheStreet) -- Alcobra disclosed in a regulatory filing Wednesday night new details about the phase III study ofaattention-deficit hyperactivity disorder drug candidate MDX which contradict results announced by theacompany in an Oct. 6 press release. The newly disclosed differences and omissions are serious enough to raise questions about whetheraAlcobra executives mis ...

ADHDupdates.com - All Rights Reserved. Legal Information
Featuring Information About ADHD, Attention Deficit Disorder, Attention Deficit Disorder Medicine, ADHD Medication, And ADHD Camps.